• Sulfamonomethoxine in Veterinary and Aquaculture Labs: Appli

  2026-06-02

  Sulfamonomethoxine (SMM) stands apart as a broad-spectrum sulfonamide antibiotic for veterinary and aquaculture research, targeting folic acid biosynthesis in pathogens. This article translates SMM’s biochemical precision into executable protocols, highlights troubleshooting strategies, and situates its environmental and resistance implications for next-generation bench science.

• Homoharringtonine Blocks SARS-CoV-2: Rapid Clearance in URT

  2026-06-02

  The referenced study demonstrates that homoharringtonine, a cytotoxic alkaloid, can rapidly clear SARS-CoV-2 from the upper respiratory tract in both animal and human models. This finding positions homoharringtonine as a promising first-line antiviral candidate for future coronavirus outbreaks.

• Malate Applications in TCA Cycle Research: Protocols & Innov

  2026-06-01

  Malate ((S)-2-hydroxysuccinic acid) is a pivotal TCA cycle intermediate for dissecting cancer metabolism, mitochondrial function, and immune modulation. This article presents stepwise protocols, advanced workflows, and troubleshooting strategies to harness malate in metabolic assays, referencing recent breakthroughs in tumor immunometabolism.

• Orientia tsutsugamushi Alters RIPK3 Without Blocking Necropt

  2026-06-01

  This study reveals that Orientia tsutsugamushi reduces cellular RIPK3 levels but does not prevent necroptosis once triggered, delineating a specific interaction with host cell death pathways. These findings clarify the pathogen's strategies for evading programmed cell death and have implications for infectious disease and cell death research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-31

  Chen et al. provide a detailed investigation of carbapenemase-encoding gene (CEG) prevalence and transfer in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong during 2022–2024. The study identifies high rates of plasmid-borne blaNDM-1 and multidrug resistance, revealing efficient gene transfer and critical implications for infection control strategies.

• LY2603618: Chk1 Inhibitor Protocols in Cancer Research

  2026-05-30

  LY2603618 empowers researchers to interrogate the DNA damage response and sensitize cancer cells to chemotherapy with precision. This guide translates cutting-edge bench protocols and troubleshooting tips for using this selective Chk1 inhibitor, especially in cell cycle and iPSC-based disease modeling.

• Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion

  2026-05-29

  The referenced study demonstrates that coil-bottlebrush diblock copolymers form robust three-dimensional network nanostructures in alkylimidazolium-based ionic liquids, with only minimal dependence on the specific ionic liquid identity. This finding broadens architectural and compositional flexibility for designing advanced polymer materials in ion-rich environments, impacting applications in membranes, energy devices, and nanofabrication.

• Cefodizime (SKU BA1050): Reliable Solutions for Antimicrobia

  2026-05-29

  This article addresses practical laboratory challenges in cell viability and antimicrobial resistance assays, demonstrating how Cefodizime (SKU BA1050) from APExBIO provides reproducible, data-backed results. By examining real-world scenarios and referencing peer-reviewed studies, it guides life science researchers toward optimized protocol design and trustworthy product selection.

• Applied Workflows for (-)-Arctigenin: MEK1 Inhibitor in Tumo

  2026-05-28

  (-)-Arctigenin, a potent MEK1 inhibitor from APExBIO, empowers researchers to dissect NF-κB and MAPK/ERK signaling in tumor microenvironment studies. This article delivers actionable protocols, troubleshooting strategies, and key insights bridging breast cancer metastasis mechanisms with advanced anti-inflammatory and antiviral research.

• BMS 599626 dihydrochloride: Reliable EGFR/ErbB2 Inhibition f

  2026-05-28

  This article provides laboratory-driven guidance on leveraging BMS 599626 dihydrochloride (SKU B5792) for high-fidelity EGFR and ErbB2 inhibition in cancer and senescence assays. Drawing from real-world workflow challenges, it evaluates experimental design, optimization, and vendor selection, linking best practices with data-backed outcomes. Researchers gain practical insights into robust assay execution using this nanomolar potency inhibitor.

• NBC19: Precision NLRP3 Inflammasome Inhibitor for Inflammati

  2026-05-27

  NBC19 delivers nanomolar precision for dissecting NLRP3-driven inflammation, with robust inhibition of IL-1β release in both Nigericin and ATP models. Integrating insights from recent clinical studies, this article details practical protocols and troubleshooting strategies to empower inflammation and metastatic niche research.

• BGJ398 (NVP-BGJ398): Unraveling FGFR2 Roles Beyond Oncology

  2026-05-27

  Explore BGJ398 (NVP-BGJ398) as more than a cancer research tool—this article reveals how its FGFR2 inhibition provides unique insights into developmental biology, connecting precise kinase targeting to cell fate and morphogenesis. Discover differentiated protocols and translational perspectives.

• PPP1R3G/PP1γ-Mediated RIPK1 Activation Drives Cell Death Pat

  2026-05-26

  This study uncovers a critical mechanism by which PPP1R3G and its catalytic partner PP1γ dephosphorylate and activate RIPK1, enabling apoptosis and necroptosis. The findings clarify regulatory steps in inflammation and cell death signaling, with implications for targeted modulation in disease models.

• Lactate-Induced Ran Lactylation Regulates Astrocyte Polariza

  2026-05-26

  This study demonstrates that lactate accumulation following spinal cord injury drives astrocyte polarization through SIRT1-regulated lactylation of the non-histone protein Ran at lysine 123. These findings clarify a metabolic-epigenetic mechanism underpinning STAT3-driven astrocyte responses, providing new molecular targets for central nervous system injury interventions.

• Molidustat (BAY85-3934): Enabling Precision in HIF Pathway M

  2026-05-25

  This article unpacks the mechanistic and translational value of Molidustat (BAY85-3934), a next-generation HIF prolyl hydroxylase inhibitor. We explore its role in erythropoietin stimulation for chronic kidney disease anemia, contextualize the latest mechanistic insights on HIF-1α regulation (anchored in new cardiac findings), and offer actionable guidance for translational researchers. The discussion spotlights APExBIO’s leadership and advances a vision for the future of oxygen-sensing therapeutics.

421 records 14/29 page Previous Next First page 上5页 1112131415 下5页 Last page